Development and clinical application of peptide-based radiopharmaceuticals.
about
Selection of radiolabeled gastrin analogs for peptide receptor-targeted radionuclide therapy.Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607.68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.Inorganic chemistry in nuclear imaging and radiotherapy: current and future directions.Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disordersEmerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders.Strain Differences Determine the Suitability of Animal Models for Noninvasive In Vivo Beta Cell Mass Determination with Radiolabeled ExendinReceptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods.Ghrelin receptor as a novel imaging target for prostatic neoplasms.In vitro structure-activity relationship of Re-cyclized octreotide analogues.Nuclear medicine imaging and therapy of neuroendocrine tumours.Pancreatic neuroendocrine tumours: established role of endoscopic ultrasound in high-risk populations.Characterization of 111In-labeled Glucose-Dependent Insulinotropic Polypeptide as a Radiotracer for Neuroendocrine Tumors.Evaluation of cholecystokinin (CCK-8) peptide thermal stability for use as radiopharmaceutical by means isothermal and nonisothermal approaches.
P2860
Q33280762-8887A500-13F6-4DD5-9CF6-4CDD1FB98269Q33884461-110C433E-3E4B-4608-BE82-D644755B82CDQ33915233-ECFCCA2B-152E-4E52-87B4-B5810F182800Q34460892-0F132A8C-B917-4B12-B913-A483D6AE2561Q36830470-ECAD3391-25D0-439C-93EF-3545174AC8E9Q36969911-EB732118-7D84-4869-B94D-A163CF5E7F7EQ37191369-E1638116-E95B-454E-AE3E-CDE6E59BAB97Q37230546-374C7ED2-9CBB-4C90-B39D-F08FC4BE7247Q37515337-6CB7EE80-1796-4C53-856C-F717402802E3Q39473579-B56A6A84-3CB7-4752-AC9E-1C8378B501D2Q39683264-BCECDF51-B905-40E4-AB21-599FCDBA0E56Q40268569-908A78D3-3793-41BC-B55A-28D1D2AB4468Q43156115-C880911E-3C39-4FE9-BE03-2580844D0E31Q49266925-25967114-880A-44DA-AB78-859885584510Q51933979-EB29ED25-08FD-423B-B3DF-2FA9C2371513
P2860
Development and clinical application of peptide-based radiopharmaceuticals.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Development and clinical application of peptide-based radiopharmaceuticals.
@ast
Development and clinical application of peptide-based radiopharmaceuticals.
@en
type
label
Development and clinical application of peptide-based radiopharmaceuticals.
@ast
Development and clinical application of peptide-based radiopharmaceuticals.
@en
prefLabel
Development and clinical application of peptide-based radiopharmaceuticals.
@ast
Development and clinical application of peptide-based radiopharmaceuticals.
@en
P2093
P356
P1476
Development and clinical application of peptide-based radiopharmaceuticals
@en
P2093
M Gotthardt
O C Boermann
P304
P356
10.2174/1381612043383502
P50
P577
2004-01-01T00:00:00Z